Artigos de revistas sobre o tema "Strophanthinum"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 45 melhores artigos de revistas para estudos sobre o assunto "Strophanthinum".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Shah, Yatin. "Strophanthin – ein besonderes Herzglykosid". Zeitschrift für Komplementärmedizin 3, n.º 02 (abril de 2011): 48–51. http://dx.doi.org/10.1055/s-0030-1270928.
Texto completo da fonteSchmidramsi, H., B. Ostermayr e J. v. Arnim. "Proving of g-strophanthin". British Homoeopathic journal 82, n.º 4 (outubro de 1993): 269. http://dx.doi.org/10.1016/s0007-0785(05)80679-9.
Texto completo da fonteTsyvunin, V. V., S. Yu Shtrygol, D. V. Shtrygol e D. P. Kavraiskyi. "Anticonvulsive potential of cardiac glycosides under conditions of pentilentetrazole-induced seizures in mice: comparative study". Acta Medica Leopoliensia 27, n.º 1-2 (junho de 2021): 63–69. http://dx.doi.org/10.25040/aml2021.01-02.063.
Texto completo da fonteVilensky, L. "Strofantin and novazurol for heart disease". Kazan medical journal 20, n.º 9 (11 de agosto de 2021): 990–91. http://dx.doi.org/10.17816/kazmj77072.
Texto completo da fonteMcKenzie, A. G. "The rise and fall of strophanthin". International Congress Series 1242 (dezembro de 2002): 95–100. http://dx.doi.org/10.1016/s0531-5131(02)00729-x.
Texto completo da fonteDadashyan, A. M. "Experience in the use of convallotoxin in circulatory failure". Kazan medical journal 43, n.º 5 (16 de novembro de 2021): 52–53. http://dx.doi.org/10.17816/kazmj87787.
Texto completo da fonteFrost, Jørgen, e Erik Warburg. "Clinical experiences concerning the effect of strophanthin". Acta Medica Scandinavica 130, S206 (24 de abril de 2009): 132–44. http://dx.doi.org/10.1111/j.0954-6820.1948.tb12030.x.
Texto completo da fonteIonova, E. O., I. A. Miroshkina, A. V. Sorokina e S. A. Kryzhanovskii. "Comparative evaluation of echocardiographic and morphometric characteristics of the rat heart left ventricle". Pharmacokinetics and Pharmacodynamics, n.º 1 (10 de maio de 2023): 41–44. http://dx.doi.org/10.37489/2587-7836-2023-1-41-44.
Texto completo da fonteGrosa, Giorgio, Gianna Allegrone e Erika Del Grosso. "LC–ESI-MS/MS characterization of strophanthin-K". Journal of Pharmaceutical and Biomedical Analysis 38, n.º 1 (junho de 2005): 79–86. http://dx.doi.org/10.1016/j.jpba.2004.12.008.
Texto completo da fonteOlesin, A. I., I. V. Konstantinova, N. N. Tyuteleva e V. S. Ivanov. "Clinical and prognostic significance of left ventricular dysfunction predictors in patients with ventricular ectopy and without structural heart disease". Fundamental and Clinical Medicine 8, n.º 3 (29 de setembro de 2023): 53–67. http://dx.doi.org/10.23946/2500-0764-2023-8-3-53-67.
Texto completo da fonteArnim, H. Schmidramsl; B. Ostermayr; J. v. "g-Strophanthin - Ergebnisse von 2 Arzneimittelprüfungen mit der 4. Dezimalpotenz". Allgemeine Homöopathische Zeitung 238, n.º 03 (4 de abril de 2007): 106–9. http://dx.doi.org/10.1055/s-2006-936451.
Texto completo da fonteChekman, I. S., N. A. Gorchakova, V. V. Bratus' e I. S. Mudraya. "Combined inotropic effect of strophanthin and calcium on heart muscle". Bulletin of Experimental Biology and Medicine 99, n.º 3 (março de 1985): 317–20. http://dx.doi.org/10.1007/bf00799077.
Texto completo da fonteGalenko-Yaroshevskii, P. A., S. M. Lemkina e Ya V. Kostin. "Drug correction of impaired strophanthin tolerance during simulated cardiac decompensation". Bulletin of Experimental Biology and Medicine 117, n.º 5 (maio de 1994): 483–86. http://dx.doi.org/10.1007/bf02444295.
Texto completo da fonteBogus, Saida K., Pavel A. Galenko-Yaroshevsky, Konstantin F. Suzdalev, Galina V. Sukoyan e Valery G. Abushkevich. "2-phenyl-1-(3-pyrrolidin-1-il-propyl)-1 H-indole hydrochloride (SS-68): Antiarrhythmic and cardioprotective activity and its molecular mechanisms of action (Part I)". Research Results in Pharmacology 4, n.º 1 (31 de agosto de 2018): 130–55. http://dx.doi.org/10.3897/rrpharmacology.4.28592.
Texto completo da fonteTawfik, Hoda, Alanna A. L. Fox e Kurt Greeff. "Comparative studies of some semisynthetic K-strophanthins with natural cardiac glycosides". Biochemical Pharmacology 34, n.º 14 (julho de 1985): 2541–47. http://dx.doi.org/10.1016/0006-2952(85)90540-4.
Texto completo da fonteKarsanov, N. V., G. V. Sukoyan, D. R. Tatulashvili, V. N. Karsanov e L. D. Mamulashvili. "Difference between mechanisms of action ofβ-acetyldigoxin, strophanthin K, and ouabain". Bulletin of Experimental Biology and Medicine 113, n.º 2 (fevereiro de 1992): 186–89. http://dx.doi.org/10.1007/bf00791495.
Texto completo da fonteKrupin, Theodore, Lisa F. Rosenberg, Arnold L. Sandridge, Charles J. Bock, Adrienne Berman e Jon M. Ruderman. "Effects of Topical K-Strophanthin on Aqueous Humor and Corneal Dynamics". Journal of Glaucoma 4, n.º 5 (outubro de 1995): 327???333. http://dx.doi.org/10.1097/00061198-199510000-00006.
Texto completo da fonteZENG, YONG-CHUN, ZHENG-JUN JIN e PEI-KUN GU. "Retinal Toxicity in Albino Rabbits Induced by Intravitreal Injection of Strophanthin-K". Journal of Ocular Pharmacology and Therapeutics 6, n.º 1 (janeiro de 1990): 51–60. http://dx.doi.org/10.1089/jop.1990.6.51.
Texto completo da fonteSobieva, Z. I., M. N. Karpova e E. G. Kryzhanovskaya. "Effect of lithium compounds on cardiac arrhythmias induced by strophanthin in conscious rats". Bulletin of Experimental Biology and Medicine 99, n.º 4 (abril de 1985): 410–13. http://dx.doi.org/10.1007/bf00842725.
Texto completo da fonteKudryavtseva, N. P., V. I. Kachurets e S. X. Nasibullina. "The use of strophanthin in the complex treatment of cardiovascular disorders in toxic diphtheria". Kazan medical journal 43, n.º 3 (29 de outubro de 2021): 42–43. http://dx.doi.org/10.17816/kazmj83692.
Texto completo da fonteÖSTLING, GUSTAF. "The Significance of the Speed of Injection for the Therapeutic Effect of K-Strophanthin". Acta Medica Scandinavica 129, n.º 1 (24 de abril de 2009): 77–80. http://dx.doi.org/10.1111/j.0954-6820.1947.tb09286.x.
Texto completo da fonteGuang-tian, Yang, e S. Daum. "Wirkung von Strophanthin, Digoxin und Isoproterenol auf die Herzkontraktilität während Hypoxie und hyperkapnischer Azidose". Journal of Tongji Medical University 6, n.º 4 (dezembro de 1986): 199–205. http://dx.doi.org/10.1007/bf02909745.
Texto completo da fonteSergeev, P. V., P. A. Galenko-Yaroshevskii, S. M. Lemkina e Ya V. Kostin. "Comparative evaluation of pharmacological effects of combined application of strophanthin with some antiadrenergic agents". Bulletin of Experimental Biology and Medicine 119, n.º 5 (maio de 1995): 484–87. http://dx.doi.org/10.1007/bf02543436.
Texto completo da fontePogorelova, V. N., A. I. Panait e A. G. Pogorelov. "Nonspecific effect of Na+/K+-ATPase inhibition with strophanthin or under hypothermia in rat heart". Biophysics 59, n.º 5 (setembro de 2014): 768–71. http://dx.doi.org/10.1134/s0006350914050212.
Texto completo da fonteRajabzoda, M. M. "Consequences of road transportation accidents, their standard growth, modern management and tactics of treatment of victims". Health care of Tajikistan, n.º 2 (21 de julho de 2022): 82–87. http://dx.doi.org/10.52888/0514-2515-2022-353-2-83-88.
Texto completo da fonteBauer, N., G. Scheiner-Bobis e W. Schoner. "„Endogenes Digitalis” – der lange Weg vom herzwirksamen pflanzlichen Toxin zum Hormon der Säuger". Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere 34, n.º 06 (2006): 389–97. http://dx.doi.org/10.1055/s-0037-1622553.
Texto completo da fonteSørensen, Else Vigholt, e Folmer Nielsen-Kudsk. "Single and combined myocardial pharmacodynamics of xamoterol, isoprenaline and g-strophanthin in the isolated rabbit heart". European Journal of Pharmacology 125, n.º 3 (junho de 1986): 363–71. http://dx.doi.org/10.1016/0014-2999(86)90792-2.
Texto completo da fonteMikhailov, I. B. "Effect of strophanthin and digoxin on activity of an experimental epileptogenic focus in the frog hippocampus". Bulletin of Experimental Biology and Medicine 104, n.º 5 (novembro de 1987): 1572–74. http://dx.doi.org/10.1007/bf00845084.
Texto completo da fonteFazulzyanov, A. A., V. M. Andreev e G. N. Fazulzyanova. "Respiratory mechanics, alveolar ventilation, ventilation-perfusion relations in the correction of heart failure with strophanthin and kapoten". Kazan medical journal 76, n.º 6 (15 de novembro de 1995): 417–19. http://dx.doi.org/10.17816/kazmj90429.
Texto completo da fonteBonah, Christian. "‘The Strophanthin question’: early scientific marketing of cardiac drugs in two national markets (France and Germany, 1900–1930)". History and Technology 29, n.º 2 (junho de 2013): 135–52. http://dx.doi.org/10.1080/07341512.2013.833039.
Texto completo da fonteHassan, A. B., M. Atef e I. M. Shihata. "Effect of Digoxin and Strophanthin on Renal Blood Flow and Systemic Blood Pressure in Normal and Bled Dogs". Zentralblatt für Veterinärmedizin Reihe A 26, n.º 2 (13 de maio de 2010): 152–58. http://dx.doi.org/10.1111/j.1439-0442.1979.tb00660.x.
Texto completo da fonteGalenko-Yaroshevskii, P. A., S. M. Lemkina e Ya V. Kostin. "Effects of the membrane stabilizer ajmaline and the local anesthetic trimecaine on the pharmacological effects of strophanthinin vivo andin vitro". Bulletin of Experimental Biology and Medicine 117, n.º 1 (janeiro de 1994): 61–64. http://dx.doi.org/10.1007/bf02444082.
Texto completo da fonteKarsanov, N. V., T. N. Macharashvili e V. A. Magaldadze. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the contractile protein system of normal cardiomyocytes". Bulletin of Experimental Biology and Medicine 108, n.º 6 (dezembro de 1989): 1735–38. http://dx.doi.org/10.1007/bf00841047.
Texto completo da fonteGalenko-Yaroshevskii, P. A., S. M. Lernkina e Ya V. Kostin. "Correction with cordarone of changes in cathepsin D activity induced by modeled circulation insufficiency and toxic action of strophanthin K". Bulletin of Experimental Biology and Medicine 122, n.º 4 (outubro de 1996): 1005–7. http://dx.doi.org/10.1007/bf02447021.
Texto completo da fonteGalenko-Yaroshevskii, P. A., S. M. Lemkina e Ya V. Kostin. "Correction of altered β-glucosidase activity induced by the toxic effect of strophanthin K and modeled cardiac decompensation with cordaron". Bulletin of Experimental Biology and Medicine 121, n.º 6 (junho de 1996): 581–83. http://dx.doi.org/10.1007/bf02447123.
Texto completo da fonteKarsanov, N. V., V. A. Magaldadze e T. N. Macharashvili. "Action of strophanthin K and ?-acetyldigoxin in vitro on energy transformation by the myocardial contractile protein system in toxico-allergic cardiomyopathy". Bulletin of Experimental Biology and Medicine 111, n.º 5 (maio de 1991): 698–700. http://dx.doi.org/10.1007/bf00841022.
Texto completo da fonteAgostoni, Pier Giuseppe, Elisabetta Doria, Marco Berti e Maurizio D. Guazzi. "Long-term use of K-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: A double-blind crossover evaluation versus digoxin". Clinical Cardiology 17, n.º 10 (outubro de 1994): 536–41. http://dx.doi.org/10.1002/clc.4960171005.
Texto completo da fonteKrvavych, Anna, e Roksolana Konechna. "Optimization of parameters of the extraction process of biologically active substances of grass Adonis vernalis". Technology audit and production reserves 3, n.º 3(59) (2 de julho de 2021): 14–18. http://dx.doi.org/10.15587/2706-5448.2021.235471.
Texto completo da fonteGalust'yan, G. �., e I. B. Mikhailov. "Effect of strophanthin and digoxin on succinate and lactate dehydrogenase and membrane Na+, K+-ATPase activity in the heart of rats with experimental myocarditis". Bulletin of Experimental Biology and Medicine 107, n.º 4 (abril de 1989): 498–500. http://dx.doi.org/10.1007/bf00842388.
Texto completo da fonteDanielopolu, D., Marin Popescu e Gr Gr Popa. "Action of Drugs on Cholinesterase and on the Adrenolytic Factors. Inactivating Action of Eserine, Strophanthin and Ascorbic Acid on Cholinesterase and on the Adrenolytic Factors." Acta Pharmacologica et Toxicologica 4, n.º 3-4 (13 de março de 2009): 339–50. http://dx.doi.org/10.1111/j.1600-0773.1948.tb03356.x.
Texto completo da fonteDatté, J. Y., e A. Ziegler. "Pharmacological investigation on nigrescigenin-a cardenolide fromParquetina nigrescens(Afzel.) Bullock: comparative studies on cardiotonic effects ofParquetina nigrescens, g-strophanthin and noradrenaline in guinea-pig isolated atria". Journal of Pharmacy and Pharmacology 53, n.º 6 (junho de 2001): 859–66. http://dx.doi.org/10.1211/0022357011776018.
Texto completo da fonteSugimoto, Jiro, Seiichi Yuasa e Masayasu Suzuki. "Comparison of Effects of Alprenolol, Carteolol, Indenolol, Pindolol, Practolol, and Propranolol in Relation to their Beta-Blocking, Local Anaesthetic, Membrane Stabilizing, and Strophanthin-G Cardiotoxicity Antagonizing Actions in Guinea-Pig". Journal of Kansai Medical University 39, n.º 4 (1987): 418–29. http://dx.doi.org/10.5361/jkmu1956.39.4_418.
Texto completo da fonteDoepp, Manfred. "May Strophanthin be a valuable cardiac drug ?" American Journal of Medical and Clinical Research & Reviews 02, n.º 09 (2023). http://dx.doi.org/10.58372/2835-6276.1069.
Texto completo da fonte"Die Lösung des Herzinfarkt-Problems durch g-Strophanthin". Erfahrungsheilkunde 53, n.º 02 (fevereiro de 2004): 65–73. http://dx.doi.org/10.1055/s-2004-819994.
Texto completo da fonteSharma, Ashish Kumar, Shivam Singh, Mehvish Bhat, Kartik Gill, Mohammad Zaid, Sachin Kumar, Anjali Shakya et al. "New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models". Scientific Reports 13, n.º 1 (29 de setembro de 2023). http://dx.doi.org/10.1038/s41598-023-41942-4.
Texto completo da fonte